Satish Nadig, MD, PhD, FACS
Satish N. Nadig, MD PhD is an adult and pediatric multiorgan transplant surgeon and Associate Professor in the Departments of Surgery, Microbiology/Immunonology, and Pediatrics-Critical Care. He currently holds an Endowed Chair in Solid Organ Transplantation and serves as the Transplant Division Director for Academic Affairs and Associate Vice Chair of Research for the Department of Surgery. Dr. Nadig founded and directs the NIH-funded Lee Patterson Allen Transplant Immunobiology Laboratory at the Medical University of South Carolina in Charleston and is the Scientific Director of the Transplant Research and ImmunoBiology Institute. Dr. Nadig holds a Doctor of Philosophy in immunology from Oxford and has served as a national and international visiting professor. He has been identified as a “Key Opinion leader” in the Transplantation Society as well as a “Rising Star” in the American Society of Transplant Surgeon. Dr. Nadig is the co-founder and Chief Medical Officer of ToleRaM Nanotech, LLC. His research interests are focused on innovations in transplantation tolerance including cellular therapy, biotechnology, and transplant immunology. Dr. Nadig was named as one of Charleston, South Carolina’s Forty under 40 in 2015, is featured in a 2016 TEDx Talk on organ donation, and has a recently published textbook entitled Technological Advances in Organ Transplantation.
Financial relationships
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.